Results 11 to 20 of about 4,427,643 (140)

Diagnosis of primary vitreoretinal lymphoma masquerading infectious retinitis by retinal biopsy. [PDF]

J Ophthalmic Inflamm Infect
Purpose To report a case of primary vitreoretinal lymphoma masquerading as infectious retinitis that was diagnosed via a retinal biopsy. Observations A 72-year-old female patient was referred to our ophthalmology clinic for evaluation of retinitis and ...
Nguyen NV, Khan F, Cannon A, Huang Y, Kim L, Xu R, Rishi P, Conrady CD, Greiner TC, Yuil-Valdes A, Yeh S.   +10 more
europepmc   +3 more sources

Primary Vitreoretinal Lymphoma Presenting Solely with Asymptomatic Peripheral Drusenoid Lesions. [PDF]

Case Rep Ophthalmol
Introduction: Primary vitreoretinal lymphoma (PVRL) is a rare malignant tumor that typically involves the retina, vitreous, or optic nerve head. PVRL often occurs concurrently with central nervous system lymphoma.
Lu B, Wong JCY, Kritzinger J, Wong DT.
europepmc   +3 more sources

Primary vitreoretinal lymphoma

Indian Journal of Ophthalmology, 2015
Primary vitreoretinal lymphoma (PVRL) is an uncommon, but potentially fatal intraocular malignancy, which may occur with or without primary central nervous system lymphoma (PCNSL).
Kaustubh Mulay, Ritesh Narula, Santosh G Honavar   +2 more
doaj   +2 more sources

Primary Vitreoretinal Lymphoma Masquerading as Refractory Retinitis

Case Reports in Ophthalmology, 2015
Purpose: To report a case of a patient with primary vitreoretinal lymphoma masquerading as retinitis. Methods: Retrospective review of the patient's clinical, histopathological and imaging records.
Ofira Zloto, Amir E. Abd Elkader, Ido Didi Fabian, Vicktoria Vishnevskia-Dai   +3 more
doaj   +2 more sources

Primary vitreoretinal lymphoma. [PDF]

Saudi J Ophthalmol, 2019
Primary vitreoretinal lymphoma (PVRL) is a rare ocular lymphoid malignancy, which consists a subset of primary central system lymphoma (PCNSL) and the most common type of intraocular lymphoma.
Kalogeropoulos D, Vartholomatos G, Mitra A, Elaraoud I, Ch'ng SW, Zikou A, Papoudou-Bai A, Moschos MM, Kanavaros P, Kalogeropoulos C.   +9 more
europepmc   +4 more sources

Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate. [PDF]

BMC Ophthalmol, 2022
Background To identify retinal changes using spectral-domain optical coherence tomography (SD-OCT) and ultra-widefield images in eyes with primary vitreoretinal lymphoma (PVRL) during intravitreal methotrexate (MTX) treatment.
Jiang T, Gu J, Liu S, Chang Q.
europepmc   +2 more sources

Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma. [PDF]

Int J Retina Vitreous, 2021
Purpose To describe the visual acuity and anatomic outcomes of intravitreal methotrexate (MTX) for the treatment of primary vitreoretinal lymphoma (PVRL).
Anthony CL, Bavinger JC, Shantha JG, O'Keefe GD, Pearce WA, Voloschin A, Grossniklaus HE, Yeh S.   +7 more
europepmc   +2 more sources

Clinical sign and symptom of primary vitreoretinal lymphoma short-time after retinal reattachment surgery: a case report. [PDF]

J Ophthalmic Inflamm Infect, 2022
Purpose To describe a case of primary vitreoretinal lymphoma (PVRL), initially presented after successful repair of rhegmatogenous retinal detachment (RRD).
Fooladi MI, Amini A, Riazi-Esfahani H, Ebrahimiadib N, Johari M, Ghassemi F.   +5 more
europepmc   +2 more sources

An unusual case report of primary vitreoretinal lymphoma

BMC Ophthalmology, 2018
Background Primary vitreoretinal lymphoma (PVRL) is a rare ocular condition and its diagnosis remains a challenge. The clinical presentation is variable and it can masquerade as chronic intermediate or posterior uveitis.
Shi Zhuan Tan, Laura R. Steeples, Ramandeep Chhabra, Nicholas P. Jones   +3 more
doaj   +2 more sources

Orelabrutinib and rituximab regimen combined with intravitreal methotrexate for treatment of primary vitreoretinal lymphoma: a case report and literature review. [PDF]

Front Oncol
Primary vitreoretinal lymphoma (PVRL) is a rare intraocular malignancy for which the optimal therapeutic strategy remains controversial, largely due to the disease’s rarity and considerable heterogeneity in treatment approaches across medical centers ...
Li Y, Qiao R, Zhang X, Li Y.
europepmc   +2 more sources